How could a new president impact the US's complex healthcare sector?

Possible pricing changes

clock • 3 min read

William Ball, senior equity analyst at Sanlam Private Wealth, analyses the US's troubled healthcare system and the changes a new president could implement in the sector, which has been at the 'heart' of the election campaigns.

Drug pricing has certainly become an emotionally charged topic during the past few months. Healthcare stocks have broadly sold off since the end of July, in part down to investors rotating out of defensive equities. Hillary Clinton (pictured) condemned the "outrageous" and "price-gouging" practices of embattled manufacturer Mylan (which has hiked the price of its decade old anti-parasitic drug EpiPen by roughly 400% since 2008), and has called for an end to "unjustified price increases not for new innovations, but for long-available and generic treatments". Earlier this month, Clinton...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on US

US adds just 12,000 jobs as unemployment rate remains unchanged
US

US adds just 12,000 jobs as unemployment rate remains unchanged

Significantly below expectations

Sorin-Andrei Dojan
clock 01 November 2024 • 2 min read
Portfolio managers take defensive stance to mitigate risk of 'coin toss' US election
US

Portfolio managers take defensive stance to mitigate risk of 'coin toss' US election

Hedging their bets

Linus Uhlig
clock 01 November 2024 • 5 min read
Morningstar's Michael Field: European equities poised for volatility amid US election outcomes
US

Morningstar's Michael Field: European equities poised for volatility amid US election outcomes

'Period of uncertainty'

Michael Field
clock 01 November 2024 • 3 min read
Trustpilot